Selected article for: "enhanced entry and host cell"

Author: Stejskal, Lenka; Kalemera, Mphatso D.; Palor, Machaela; Walker, Lucas; Daviter, Tina; Lees, William D.; Moss, David S.; Kremyda-Vlachou, Myrto; Kozlakidis, Zisis; Rosenberg, William; Illingworth, Christopher J. R.; Shepherd, Adrian J.; Grove, Joe
Title: An Entropic Safety Catch Controls Hepatitis C Virus Entry and Antibody Resistance
  • Cord-id: voy943y4
  • Document date: 2020_11_16
  • ID: voy943y4
    Snippet: E1 and E2 (E1E2), the entry proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain unknown. Hypervariable region-1 (HVR-1) of E2 is a putative intrinsically disordered protein tail. Here, we demonstrate that HVR-1 has an autoinhibitory function that suppresses the activity of E1E2 on free virions; this is dependent on its conformational entropy. Crucially, to allow entry, this mechanism is turned off
    Document: E1 and E2 (E1E2), the entry proteins of Hepatitis C Virus (HCV), are unlike that of any other virus yet described, and the detailed molecular mechanisms of HCV entry/fusion remain unknown. Hypervariable region-1 (HVR-1) of E2 is a putative intrinsically disordered protein tail. Here, we demonstrate that HVR-1 has an autoinhibitory function that suppresses the activity of E1E2 on free virions; this is dependent on its conformational entropy. Crucially, to allow entry, this mechanism is turned off by host receptor interactions at the cell surface. Thus, HVR-1 is akin to a safety catch on E1E2 activity. Mutations that reduce conformational entropy in HVR-1, or genetic deletion of HVR-1, turn off the safety catch to generate hyper-reactive HCV that exhibits enhanced virus entry but is thermally unstable and acutely sensitive to neutralising antibodies. Therefore, the HVR-1 safety catch controls the efficiency of virus entry and maintains resistance to neutralising antibodies.

    Search related documents:
    Co phrase search for related documents
    • absence presence and active process: 1, 2, 3
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and additional mutation: 1, 2, 3
    • absence presence and log function: 1
    • absence presence and log linear: 1